FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281560766> ?p ?o ?g. }

• W4281560766 endingPage "2682" @default.
• W4281560766 startingPage "2667" @default.
• W4281560766 abstract "Aim: To assess invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS) in hormone receptor-positive, HER2-negative early breast cancer with combined clinicopathological criteria from monarchE, a phase III study of abemaciclib. Methods: US electronic health records were used to compare outcomes between high-risk (≥4 lymph nodes, or 1-3 lymph nodes and grade 3, tumor ≥5 cm or Ki-67 ≥20%) versus nonhigh-risk groups using Kaplan-Meier methods and Cox regression models. Results: The high-risk group (n = 557) was at higher risk for IDFS and DRFS events than the nonhigh-risk group (n = 3471). IDFS events (hazard ratio: 3.07; 95% CI: 2.45-3.83) and DRFS events (hazard ratio: 3.15; 95% CI: 2.49-3.97) were significantly higher for the high-risk group. Conclusion: Risk of recurrence was three-times greater in the high-risk group, highlighting the need for better therapies.Breast cancer is frequently diagnosed early, at a stage when patients can be cured. However, some patients have breast cancers (tumors) with a high risk of recurrence. When cancers come back, a cure is often not possible. This study looks at multiple high-risk tumor features and the risk of cancer returning, in the most common breast cancer type, known as hormone receptor-positive, HER2-negative breast cancer. In patients with high-risk tumors, breast cancer returned in about 11.9% of patients within 2 years and in 29.8% of patients at 5 years. The risk of recurrence or death was three-times higher in patients with high-risk tumors compared to patients with nonhigh-risk tumors. These results suggest better treatments are needed to prevent breast cancers from coming back in patients at high risk of recurrence." @default.
• W4281560766 created "2022-05-27" @default.
• W4281560766 creator A5003889471 @default.
• W4281560766 creator A5013007948 @default.
• W4281560766 creator A5018512578 @default.
• W4281560766 creator A5021935697 @default.
• W4281560766 creator A5029359855 @default.
• W4281560766 creator A5043605449 @default.
• W4281560766 creator A5056462668 @default.
• W4281560766 creator A5082016998 @default.
• W4281560766 creator A5086108457 @default.
• W4281560766 date "2022-07-01" @default.
• W4281560766 modified "2023-09-30" @default.
• W4281560766 title "A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer" @default.
• W4281560766 cites W1497013683 @default.
• W4281560766 cites W1529243395 @default.
• W4281560766 cites W1531348775 @default.
• W4281560766 cites W1924240366 @default.
• W4281560766 cites W1961026612 @default.
• W4281560766 cites W2080545389 @default.
• W4281560766 cites W2096864872 @default.
• W4281560766 cites W2103063413 @default.
• W4281560766 cites W2117228403 @default.
• W4281560766 cites W2134807611 @default.
• W4281560766 cites W2136839015 @default.
• W4281560766 cites W2165597190 @default.
• W4281560766 cites W2203649236 @default.
• W4281560766 cites W2279220517 @default.
• W4281560766 cites W2318605753 @default.
• W4281560766 cites W2417623773 @default.
• W4281560766 cites W2495668504 @default.
• W4281560766 cites W2572585609 @default.
• W4281560766 cites W2728077452 @default.
• W4281560766 cites W2762092204 @default.
• W4281560766 cites W2767600184 @default.
• W4281560766 cites W2768080316 @default.
• W4281560766 cites W2795120383 @default.
• W4281560766 cites W2799954804 @default.
• W4281560766 cites W2800158081 @default.
• W4281560766 cites W2804210712 @default.
• W4281560766 cites W2806471440 @default.
• W4281560766 cites W2885668565 @default.
• W4281560766 cites W2898952791 @default.
• W4281560766 cites W2904991649 @default.
• W4281560766 cites W2905545945 @default.
• W4281560766 cites W2912834234 @default.
• W4281560766 cites W2917102036 @default.
• W4281560766 cites W2923800831 @default.
• W4281560766 cites W2977497532 @default.
• W4281560766 cites W3011104356 @default.
• W4281560766 cites W3014998117 @default.
• W4281560766 cites W3087520429 @default.
• W4281560766 cites W3110569062 @default.
• W4281560766 cites W3112570855 @default.
• W4281560766 cites W3120241209 @default.
• W4281560766 cites W3128646645 @default.
• W4281560766 cites W3130416374 @default.
• W4281560766 cites W3131900383 @default.
• W4281560766 cites W3148345241 @default.
• W4281560766 cites W3162883085 @default.
• W4281560766 cites W3165576985 @default.
• W4281560766 cites W3206169364 @default.
• W4281560766 cites W4200029460 @default.
• W4281560766 cites W4206349107 @default.
• W4281560766 cites W4226218519 @default.
• W4281560766 cites W4241664300 @default.
• W4281560766 cites W4376849581 @default.
• W4281560766 cites W3111725766 @default.
• W4281560766 doi "https://doi.org/10.2217/fon-2022-0310" @default.
• W4281560766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35611679" @default.
• W4281560766 hasPublicationYear "2022" @default.
• W4281560766 type Work @default.
• W4281560766 citedByCount "8" @default.
• W4281560766 countsByYear W42815607662022 @default.
• W4281560766 countsByYear W42815607662023 @default.
• W4281560766 crossrefType "journal-article" @default.
• W4281560766 hasAuthorship W4281560766A5003889471 @default.
• W4281560766 hasAuthorship W4281560766A5013007948 @default.
• W4281560766 hasAuthorship W4281560766A5018512578 @default.
• W4281560766 hasAuthorship W4281560766A5021935697 @default.
• W4281560766 hasAuthorship W4281560766A5029359855 @default.
• W4281560766 hasAuthorship W4281560766A5043605449 @default.
• W4281560766 hasAuthorship W4281560766A5056462668 @default.
• W4281560766 hasAuthorship W4281560766A5082016998 @default.
• W4281560766 hasAuthorship W4281560766A5086108457 @default.
• W4281560766 hasBestOaLocation W42815607661 @default.
• W4281560766 hasConcept C121608353 @default.
• W4281560766 hasConcept C126322002 @default.
• W4281560766 hasConcept C143998085 @default.
• W4281560766 hasConcept C146357865 @default.
• W4281560766 hasConcept C151730666 @default.
• W4281560766 hasConcept C207103383 @default.
• W4281560766 hasConcept C23589133 @default.
• W4281560766 hasConcept C2779134260 @default.
• W4281560766 hasConcept C44249647 @default.
• W4281560766 hasConcept C50382708 @default.
• W4281560766 hasConcept C530470458 @default.
• W4281560766 hasConcept C71924100 @default.

• next